Advertisement American Pacific reports increased Q2 net income - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

American Pacific reports increased Q2 net income

American Pacific Corporation, a manufacturer of fine chemicals and specialty chemicals, has reported a net income of $2.73m, or $0.34 per diluted share, for the second quarter ended 31 March 2013 compared to $1.05m, or $0.16 per diluted share, for the second quarter ended 31 March 2012.

Revenues for the second quarter ended 31 March 2013 were $50.04m compared to $39.92m for the second quarter ended 31 March 2012.

Net income for the first six months ended 31 March 2013 were $3.89m, or $0.49 per diluted share, compared to net income of $1.21m, or $0.17 per diluted share, for the first six months ended 31 March 2012.

The company has posted revenues of $86.36m, for the first half ended 31 March 2013, compared to $78.4m for the same period ended 31 March 2012.

The company increased its guidance for Fiscal 2013 and expects consolidated revenues of at least $205m and Adjusted EBITDA of at least $47m.

The company also provides active pharmaceutical ingredients and advanced intermediates to the pharmaceutical industry.